Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Oral Polypodium Leucotomos on Visible Light Induced Skin Pigmentation
NCT02904798Completed
- Sponsor
- Henry Ford Health
- Start
- Jul 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Polypodium leucotomos in photodermatosis, sponsored by Henry Ford Health. Primary endpoint: Difference in pigmentation pre and post administration of oral PLE at 42 days. Started Jul 2015; status: completed.
02
Drugs
Polypodium leucotomos
03
Conditions
photodermatosis
Beyond the preview
Go deeper on NCT02904798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02904798.